Children's Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research
Summary
Funds will support research to identify promising treatments for patients with NF1PHILADELPHIA, April 4, 2023 /PRNewswire/ -- (CHOP) today announced that it has received more than $10 million in a series of gifts to fund critical neurofibromatosis research from the , a private foundation established by Dan and Jennifer Gilbert to accelerate a cure for (NF1).NF1 is a genetic disorder that can affect multiple systems of the body and is characterized by symptoms that include skin changes, skeletal abnormalities, and tumors. Using computational methods and novel approaches, the researchers hope to identify a unique tumor antigen that can be targeted using CAR T-cell therapy. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the 595-bed hospital has fostered many discoveries that have benefited children worldwide. The Gilbert Family Foundation supports groundbreaking, cutting-edge research in hopes of eradicating NF1, a genetic disorder that causes tumors to grow on nerves anywhere in the body. Additionally, the Foundation supports the economic stability and mobility of residents in Detroit by investing in wealth-building opportunities and breaking down systemic barriers.